CoChat

Combinatorial targeting of TSLP, IL-25, and IL-33 in type 2 cytokine–driven inflammation and fibrosis

Open access

The DOI matches its Crossref record; 65 of the 65 references it cites were found in a registry or an index.

Abstract

Thymic stromal lymphopoietin (TSLP), interleukin-25 (IL-25), and IL-33 are important initiators of type 2-associated mucosal inflammation and immunity. However, their role in the maintenance of progressive type 2 inflammation and fibrosis is much less clear. Using chronic models of helminth infection and allergic lung inflammation, we show that collective disruption of TSLP, IL-25, and IL-33 signaling suppresses chronic and progressive type 2 cytokine-driven inflammation and fibrosis. In a schistosome lung granuloma model or during chronic Schistosoma mansoni infection in the liver, individual ablation of TSLP, IL-25, or IL-33/ST2 had no impact on the development of IL-4/IL-13-dependent inflammation or fibrosis. However, significant reductions in granuloma-associated eosinophils, hepatic fibrosis, and IL-13-producing type 2 innate lymphoid cells (ILC2s) were observed when signaling of all three mediators was simultaneously disrupted. Combined blockade through monoclonal antibody (mAb) treatment also reduced IL-5 and IL-13 expression during primary and secondary granuloma formation in the lungs. In a model of chronic house dust mite-induced allergic lung inflammation, combined mAb treatment did not decrease established inflammation or fibrosis. TSLP/IL-33 double-knockout mice treated with anti-IL-25 mAb during priming, however, displayed decreased inflammation, mucus production, and lung remodeling in the chronic phase. Together, these studies reveal partially redundant roles for TSLP, IL-25, and IL-33 in the maintenance of type 2 pathology and suggest that in some settings, early combined targeting of these mediators is necessary to ameliorate progressive type 2-driven disease.

Overview

Integrity signals

Registry

Crossref · 10.1126/scitranslmed.aaf1938

Cites

65 of 65 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

We couldn’t retrieve this paper’s full text, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Citations

Cites

Show all 65 references

Research works printed but not linked: 1

  1. T. A. Wynn L. Barron R. W. Thompson S. K. Madala M. S. Wilson A. W. Cheever T. Ramalingam in Current Protocols in Immunology John E. Coligan et al. Eds. (John Wiley & Sons Inc. New York 2011).

Cited by

See all 188

Metadata

Authors
Vannella, K. M., Ramalingam, T. R., Borthwick, L. A., Barron, L., Hart, K. M., Thompson, R. W., Kindrachuk, K. N., Cheever, A. W., White, S., Budelsky, A. L., Comeau, M. R., Smith, D. E., & Wynn, T. A.
Affiliations
  • National Institutes of Health (US)
  • Amgen (United States) (US)
Corresponding author
Wynn, Thomas A.
Venue
Science Translational Medicine
Published
2016-05-04
Volume
8
Issue
337
Pages
337ra65-337ra65
ISSN
  • 1946-6234 (ISSN-L)
  • 1946-6242
OpenAlex
W2345448809
Cited by
188
References
64
Citations by year
2026: 15 · 2025: 10 · 2024: 19 · 2023: 13 · 2022: 21 · 2021: 18 · 2020: 19 · 2019: 24 · 2018: 20 · 2017: 25 · 2016: 4
FWCI
14.73
Type
journal article
Language
en
Open access
Locations
  • Science Translational Medicine (publishedVersion)
  • PubMed (publishedVersion)
  • Newcastle University ePrints (Newcastle Univesity)
Funders
  • Intramural Research Program of NIH
  • National Institute of Allergy and Infectious Diseases
Topics
  • Life Sciences › Immunology and Microbiology › Immunology › IL-33, ST2, and ILC Pathways
  • Health Sciences › Medicine › Pulmonary and Respiratory Medicine › Asthma and respiratory diseases
  • Life Sciences › Immunology and Microbiology › Parasitology › Parasites and Host Interactions
Keywords
thymic stromal lymphopoietin, IL-25, IL-33, ST2, type 2 inflammation, fibrosis, helminthiasis, Schistosoma mansoni, lung granulomas, eosinophils, ILC2, IL-13, IL-4, allergic lung inflammation, house dust mites, mucus production, lung remodeling, monoclonal antibodies
MeSH terms
Interleukin-33, Thymic Stromal Lymphopoietin, Animals, Antibodies, Monoclonal, Female, Fibrosis, Granuloma, Inflammation, Lung Neoplasms, Male, Mice, Inbred BALB C, Mice, Inbred C57BL, Schistosoma mansoni, Interleukin-4, Cytokines, Mice, Knockout, Interleukin-13, Interleukin-17, Mice

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Combinatorial targeting of TSLP, IL-25, and IL-33 in type 2 cytokine–driven inflammation and fibrosis. https://app.cochat.ai/papers/10.1126/scitranslmed.aaf1938
The paper
Vannella, K. M., Ramalingam, T. R., Borthwick, L. A., Barron, L., Hart, K. M., Thompson, R. W., Kindrachuk, K. N., Cheever, A. W., White, S., Budelsky, A. L., Comeau, M. R., Smith, D. E., & Wynn, T. A. (2016). Combinatorial targeting of TSLP, IL-25, and IL-33 in type 2 cytokine–driven inflammation and fibrosis. Science Translational Medicine. https://doi.org/10.1126/scitranslmed.aaf1938

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.